ten most valuable companies in Europe

AdminOctober 27, 2024

0 12 4 minutes read

Like big fortunes, the valuations of the companies with the highest market capitalizations are closely tied to the United States: 15 of the 17 companies are among the most traded companies, with companies from the technology sector virtually dominating the list. Europe, to a lesser extent, also boasts some of these, with the pharmaceutical industry at the forefront of this network.

You’ll have to go all the way to 18th place to find the first European company with the highest capitalization, like this Nordisk. The Danish company is valued at $513.37 billion, thanks in part to its drug Ozempic, which allowed the company to even surpass LVMH. The Gala is the second largest European lottery with a value of $344.13 billion. The 26th-ranked luxury firm led by Bernard Arnault is having a tough time: its latest results for September showed its first sales decline since the pandemic; while revenue reached $65.64 billion in the first nine months of the year, representing a 2% decline compared to the figure reported in the same period the previous year and the worst sales performance since the second quarter of 2020.

Third place among large listed companies in Europe belongs to ASML. The 32nd-ranked Dutch technology company hit $415.95 billion on Oct. 10, overtaking LVMH to become the first European company to list. However, a sharp drop in the company’s share price a week ago has lowered its value today to $283.56 billion. Despite this, the firm is expected to return to its strengths with very attractive potential. it will recover as it comes out of the recession it is currently in. Behind her is GLANDERSanother technological one, but of German origin. On Tuesday, the company reported third-quarter results that were evidence of the good times the company’s business is going through and its strong near-term prospects. At the beginning of the year, the company announced a restructuring that is bearing fruit: the focus is on artificial intelligence. At the moment, its capitalization is $283.56 billion.

The first pharmacist on the list matches Rocheoccupying fifth place among large listed companies in Europe. The market value of the Swiss company reaches $259.72 billion. The group’s sales rose 6% in the first nine months, driven by strong demand for both of its drugs Vabism (serious eye diseases), Fesgo (breast cancer) and Ocrevus (multiple sclerosis). In the third quarter, the company’s sales grew 9%, the same as in the second quarter. After her there is another Swiss woman, but from the food sector. Nestléwith a market value of $253.38 billion. 2024 will not go down in history for the company, which recorded a turnover of $77.23 billion in the nine months of 2024, down 2.4% compared to the same period last year. The decline was partly due to exchange rate effects and weak consumer demand, according to the multinational.

In seventh place is HermesWith a market capitalization of $239.85 billion, it is the only luxury brand that has managed to overcome the turbulence that the sector is experiencing. The gala caps off the first nine months of the year by boosting sales. While LVMH and Kering ended the period with lower sales, the French luxury group ended the period with higher turnover, helped by strong results in Asia. Hermès, in particular, ended the period with sales of $12.11 billion, up 11.4% from the same period the previous year. And all thanks to the good behavior of the Asian consumer. In the Japanese and Asia-Pacific markets, the group generated sales of $6.65 billion, up 6% from 2023. “In an even more uncertain economic and geopolitical context, I want to thank all employees for the strong results in the third quarter and our customers for their loyalty,” Axel Dumas, executive president of Hermès, wanted to publicly express his opinion.

AstraZeneca It ranks eighth with a market value of $237.46 billion. The British company increased revenue by 18% in the first half and raised its full-year forecasts. On August 31, it reached its maximum values, reaching a value of about 275 billion. Since then, the pharmaceutical company has maintained acceptable numbers. Novartisalso operating in the pharmaceutical sector, is the ninth company with the highest market value. The Swiss company reaches $230.86 billion. And in tenth place is Accenture. The Irish company, one of the most important management consultancies, ended its full year with revenue of $64.9 billion, up 2% on the previous year. According to him, the transnational corporation is growing in three out of five business areas: resources (+4%); Healthcare and public sector (+10%); Industry, consumption and distribution (+2%). In contrast, its business contracts are in financial services (-3%) and communications, media and technology (-4%). Its market value is $228.73 billion.